Prelation Biopharma Llp - Company Profile

It is a chemicals limited liability partnership based in Hyderabad, Telangana, India, established in 2021.
2021 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Prelation Biopharma Llp

Prelation Biopharma Llp, a active limited liability partnership, was established on 12 March 2021 in Hyderabad, Telangana, India. Engaging in chemicals and chemical products within the chemicals sector, it holds LLPIN: AAW-2890. Registered under ROC Roc Hyderabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Yash Bathla (Designated Partner), Lakshmi Bathla (Designated Partner), Shwetha Bathla (Designated Partner). It is based at Plot No. B2, Sy No. 6/1 Quiet Lands, Gachi Bowli, Serlingampally, Hyderabad, Telangana, 500019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAW-2890

  • Incorporation Date

    12 March 2021

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 5 Year, 3 Months
Company report

Prelation Biopharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Prelation Biopharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Prelation Biopharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Yash Bathla Designated Partner 12 Mar 2021 Current
Lakshmi Bathla Designated Partner 12 Mar 2021 Current
Shwetha Bathla Designated Partner 12 Mar 2021 Current
Sanjay Bathla Designated Partner 12 Mar 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Prelation Biopharma Llp.

Enhance accessibility to Prelation Biopharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Prelation Biopharma Llp revenue growth over time
Prelation Biopharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Prelation Biopharma Llp?

Unlock access to Prelation Biopharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Prelation Biopharma Llp?

Unlock and access historical data on people associated with Prelation Biopharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Prelation Biopharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prelation Biopharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Prelation Biopharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Prelation Biopharma Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was completed.

  • Director Appointment

    The activity Yash Bathla was appointed as a Designated Partner was appointed as a Designated Partner on 12 Mar 2021 & has been associated with this company since 5 years 3 months . was completed.

  • Director Appointment

    Lakshmi Bathla was appointed as a Designated Partner was appointed as a Designated Partner on 12 Mar 2021 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    Shwetha Bathla was appointed as a Designated Partner was appointed as a Designated Partner on 12 Mar 2021 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • Director Appointment

    Sanjay Bathla was appointed as a Designated Partner was appointed as a Designated Partner on 12 Mar 2021 & has been associated with this company since 5 years 3 months . was recorded as a recent event.

  • LLP Incorporation

    The activity Prelation Biopharma Llp was registered on 12 Mar 2021 with Roc Hyderabad & aged 5 years 3 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Prelation Biopharma Llp?

The LLPIN of Prelation Biopharma Llp is AAW-2890.

Where is Prelation Biopharma Llp headquartered?

Prelation Biopharma Llp is headquartered at Plot No. B2, Sy No. 6/1 Quiet Lands, Gachi Bowli, Serlingampally, Hyderabad, Telangana, 500019.

When was Prelation Biopharma Llp incorporated?

Prelation Biopharma Llp was incorporated on 12 March 2021.

Who are the current directors of Prelation Biopharma Llp?

The current directors of Prelation Biopharma Llp are

What is the primary industry of Prelation Biopharma Llp?

The primary industry of Prelation Biopharma Llp is Chemicals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available